XML 35 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Net Income (Loss) per Share (Tables)
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Summary of Earnings Per Share
The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders for the three and nine months ended September 30, 2021 and 2020:
Three Months Ended September 30,Nine Months Ended September 30,
2021202020212020
(in thousands, except shares and per share data)
Basic net income (loss) per share:
Numerator
Net income (loss)$29,414 $(71,133)$118,242 $(112,766)
Preferred distribution to redeemable convertible Series C preferred units— — — (40,689)
Non-cash adjustment to redemption amount of the redeemable convertible Series C preferred units— — — 47,537 
Net income (loss) attributable to common stockholders$29,414 $(71,133)$118,242 $(105,918)
Denominator
Weighted average common shares126,190,351 115,189,532 126,405,822 67,828,046 
Basic net income (loss) per share attributable to common stockholders$0.23 $(0.62)$0.94 $(1.56)
Diluted net income (loss) per share:
Numerator
Net income (loss) attributable to common stockholders$29,414 $(71,133)$118,242 $(105,918)
Denominator
Basic weighted average common shares126,190,351 115,189,532 126,405,822 67,828,046 
Dilutive effect of outstanding Time-Based Restricted Stock Units57,148 — 45,297 — 
Diluted weighted average common shares126,247,499 115,189,532 126,451,119 67,828,046 
Diluted net income (loss) per share attributable to common stockholders$0.23 $(0.62)$0.94 $(1.56)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potentially dilutive outstanding securities for the three and nine months ended September 30, 2021 and 2020 were excluded from the computation of diluted net income (loss) per share because their effect would have been anti-dilutive for the periods presented, or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the periods:
Three Months Ended September 30,Nine Months Ended September 30,
2021202020212020
Unvested Stock Options195,896  195,896  
Unvested Performance-Based Restricted Stock Units99,289  99,289  
Redeemable stock warrants 2,230,897  890,291 
Contingency consideration 5,803,329  4,032,276 
Retroactively restated Series C preferred units —  8,389,982 
Total295,185 8,034,226 295,185 13,312,549